SBC Medical Group Holdings Inc (SBC)

Featured in Small-Cap Stocks

SBC Medical Group Holdings Inc is a healthcare company listed on the NASDAQ under the symbol SBC. Through its subsidiaries, the group provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. Its service mix includes advertising and social media marketing, staffing and training, appointment booking, housing rental support for franchise employees, clinic design and leasehold improvement services, and procurement of medical equipment and consumables. The company also provides consulting, loyalty program administration, IT software solutions, and franchising-related support, while distributing medical devices, implants, injection materials, skin care products, beauty products, and other consumables to franchisee clinics. In addition, SBC Medical Group operates treatment centers under the SBC brand and offers a wide range of surgical and non-surgical cosmetic procedures. Founded in 2000, the company is headquartered in Irvine, California.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-SBC
$4.22
41.1% Upside
Undervalued
$8.50
184.3% Upside
Bargain
Great
0.0%
August 19, 2026
7.6x
1.2x
1.8x
312.7 M
168.8 M
13.7%
17.6%
4.5
73.1%
Valuation • Fair Value

SBC Medical Group Holdings Inc (NASDAQ-SBC) Fair Value by Valuation Model

Compare the primary fair value estimate for SBC Medical Group Holdings Inc (NASDAQ-SBC) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$4.22

Estimated upside of 41.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$5.66

Discounted cash flow valuation reference.

Ben Graham Formula Value

$4.40

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$5.78

Earnings power value estimate.

Comps Fair Value

$3.48

Comparable-company valuation reference.

Analyst Price Target

$8.50

Analysts imply upside of 184.3%.

How to read these valuation models

Use this section to compare the primary fair value estimate for SBC Medical Group Holdings Inc (NASDAQ-SBC) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for SBC Medical Group Holdings Inc (NASDAQ-SBC)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

169.3 M

Current operating scale indicator.

Revenue Forecast

182.2 M

Forward revenue estimate.

EBITDA

63.731 M

Current operating profitability reference.

EBITDA Forecast

77.24 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review SBC Medical Group Holdings Inc (NASDAQ-SBC) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for SBC Medical Group Holdings Inc (NASDAQ-SBC)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Great

Positive financial-health read.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

-1.86

Intermediate zone that deserves monitoring.

Altman Z-Score

4.5

Relatively strong balance-sheet zone.

FCF / Net Income

73.1%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for SBC Medical Group Holdings Inc (NASDAQ-SBC). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for SBC Medical Group Holdings Inc (NASDAQ-SBC)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 19, 2026

Days to Earnings

29

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for SBC Medical Group Holdings Inc (NASDAQ-SBC), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

SBC Medical Group Holdings Inc (NASDAQ-SBC) Stock Forecast & Technical Outlook

Review SBC Medical Group Holdings Inc (NASDAQ-SBC) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for SBC Medical Group Holdings Inc (NASDAQ-SBC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for SBC Medical Group Holdings Inc (NASDAQ-SBC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for SBC Medical Group Holdings Inc (NASDAQ-SBC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for SBC Medical Group Holdings Inc (NASDAQ-SBC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for SBC Medical Group Holdings Inc (NASDAQ-SBC) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for SBC Medical Group Holdings Inc (NASDAQ-SBC)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, SBC Medical Group Holdings Inc (NASDAQ-SBC) has a Strong Buy consensus, with 2 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 2
Hold 0
Sell 0
FAQ Fast Investor Answers

SBC Medical Group Holdings Inc (NASDAQ-SBC) Stock FAQ

Quick answers about SBC Medical Group Holdings Inc (NASDAQ-SBC) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$4.22
Estimated upside 41.1%
Valuation Rating
Undervalued
Estimated upside of 41.1%
Analyst Target
$8.50
Implied upside 184.3%
Financial Health
Great
Current financial-health read

The current fair value estimate for SBC Medical Group Holdings Inc (NASDAQ-SBC) is $4.22. This implies an estimated upside of 41.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 41.1% versus the current market price.

The available analyst price target for SBC Medical Group Holdings Inc (NASDAQ-SBC) is $8.50. The analyst target implies estimated upside of 184.3%.

The current financial health read for SBC Medical Group Holdings Inc (NASDAQ-SBC) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for SBC Medical Group Holdings Inc (NASDAQ-SBC) is August 19, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for SBC Medical Group Holdings Inc (NASDAQ-SBC) is 7.6x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for SBC Medical Group Holdings Inc is 312.7 M.

The current enterprise value listed for SBC Medical Group Holdings Inc is 168.8 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for SBC Medical Group Holdings Inc is NASDAQ-SBC, and the stock is listed on NASDAQ.

SBC Medical Group Holdings Inc (NASDAQ-SBC) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for SBC Medical Group Holdings Inc is 13.7%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for SBC Medical Group Holdings Inc is 17.6%. Free float helps investors understand how much of the share base is available for public trading.